About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Signs Development Agreement for TPM Oxymorphone Patch in Japan

August 22, 2017

Click here to read more

Post navigation

Phosphagenics Sells BioElixia Beauty Brand to Pure Beauty Australia

June 2017 Half Year Financial Report and Appendix 4D

Related Posts

Updated Non-Confidential Presentation CEO USA Roadshow

August 13, 2018

Phosphagenics Signs a Multinational License for TPM® in Personal Care Products

December 4, 2017

Phosphagenics Signs Japanese License Option Agreement for TPM Oxycodone Patch

May 17, 2016

Recent Posts

Media Coverage | Nine News
October 21, 2024
First Patient Dosed in Phase III Insomnia Trial
May 16, 2024
MEDIA | Channel 9 News
March 28, 2024

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.